Pharmaceuticals - Publications - Faculty & Research

09 Jan 2007
First Look

First Look: January 9, 2007

http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=707413 Teva Pharmaceutical Industries, Ltd. Harvard Business School Case 707-441 Purchase this case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=707441 ... View Details

Keywords: Martha Lagace

03 Mar 2015
First Look

First Look: March 3

model, the company would sell sequencers at a higher price to those entities that already purchased sequencers, primarily major research labs and pharmaceutical firms, but position its machine as a faster alternative to existing... View Details

Keywords: Sean Silverthorne

May 25, 2016
Comment

How Consumers and Businesses are Reshaping Public Health

By: John A. Quelch

Healthcare and education are two issues in which citizens around the world, rich and poor, are passionately interested. It has long been appreciated that the way that a society treats its youngest and oldest members says much about its moral maturity. Economic... View Details

Citation

Read Now

07 Oct 2014
First Look

First Look: October 7

(MMRC), and brought together a diverse body of academics, researchers, pharmaceutical and biotech companies, physicians, and patients to combine their efforts around the disease. The MMRF had helped facilitate clinical trials for... View Details

Keywords: Sean Silverthorne

05 Aug 2014
First Look

First Look: August 5

Case 614-063 Merrimack Pharmaceuticals, Inc. (A) In 2006, Merrimack Pharmaceuticals was a fast-growing biotechnology company. Its leadership team was divided over whether to keep R&D organized in functional departments or transition... View Details

Keywords: Sean Silverthorne

Research Summary

Overview

Dr. Crawford conducts research on innovation in the energy industry, with a special focus on emerging business models. She is developing several cases for the EC course, "21st Century Energy," that specifically examine innovations at the interface of IT and Energy — ... View Details

January 2007 (Revised January 2007)
Background Note

Note on the U.S. Food and Drug Administration

By: Robert F. Higgins, Richard G. Hamermesh and Virginia Fuller

Describes the U.S. FDA with particular emphasis on its role in the development of new drugs, biologic products, and medical devices today. Provides context for the drug approval process by describing the FDA's history and organizational structure. View Details

Keywords: Health; Governance Compliance; Policy; Product Development; Government and Politics; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States

Citation

Educators

Purchase

25 Feb 2014
First Look

First Look: February 25

Laboratories' Proposed Merger with King Pharmaceutical Perry Capital owns shares in King and, to facilitate approval of the merger, buys shares in Mylan, whilst hedging out its economic exposure to Mylan's share price using derivatives.... View Details

Keywords: Sean Silverthorne

June 2024
Supplement

Legacy Partners (A)

By: Richard S. Ruback and Royce Yudkoff

Instructors should consider the timing of making videos available to students, as they may reveal key case details.

Stephen Holbrook and Austin Pulsipher (both HBS '19) had been leading Nutrishare since acquiring the company six months earlier in mid-2021.... View Details

Citation

Purchase

23 May 2017
First Look

First Look at New Ideas and Research: May 23, 2017

of one of the top pharmaceutical companies in the world. Vasella, an avowed advocate of diversification, had expanded the scope of the company and structured it into 16 distinct business units ranging from animal health to oncology while... View Details

Keywords: Carmen Nobel

2011
Article

Strategic Change and the Jazz Mindset: Exploring Practices That Enhance Dynamic Capabilities for Organizational Improvisation

By: Ethan S. Bernstein and Frank J. Barrett

How can leaders adopt a mindset that maximizes learning, remains responsive to short-term emergent opportunities, and simultaneously strengthens longer-term dynamic capabilities of the organization? This chapter explores the organizational decisions and practices... View Details

Citation

Read Now

Purchase

20 Jan 2015
First Look

First Look: January 20

School Case 514-084 Vision 2020: Takeda and the Vaccine Business In 2014, Yasuchika Hasegawa was orchestrating the transformation of Takeda from a Japanese pharmaceutical company with a global footprint into a global company with a... View Details

Keywords: Sean Silverthorne

03 Sep 2013
First Look

First Look: September 3

Research Center: Growing a Joint Research Venture in India Bristol Myers Squibb, a multi-national pharmaceutical company, is seeking to globalize its R&D strategy while managing costs. It has formed a joint venture with an Indian... View Details

Keywords: Sean Silverthorne

01 Jul 2008
First Look

First Look: July 1, 2008

establish a proposed alliance with a pharmaceutical firm? Should it create a nutraceuticals business in parallel to its effort to develop anti-aging therapeutics? And, should it in-license a second drug development candidate? Purchase... View Details

Keywords: Martha Lagace

March 2015
Teaching Note

CVS Health: Promoting Drug Adherence

By: Leslie John, John Quelch and Robert Huckman

Email mking@hbs.edu for a courtesy copy.

This Teaching Note explains the theory of the case and teaching plan for the case: CVS Health: Promoting Drug Adherence (515010). The case finds Helena Foulkes, Executive... View Details

Citation

Purchase

Article

What to Know About Locating in a Cluster

By: Willy C. Shih and Sen Chai

As a study of two industry clusters in Denmark shows, factors that can make clusters attractive—easy people movement and knowledge spillovers—can also make it harder for individual companies to retain proprietary knowledge. View Details

Keywords: Clusters; Clustering; Competitiveness; Life Sciences; Telecommunications; Science-based; Research And Development; Industry Clusters; Research; Innovation Strategy; Innovation and Management; Geographic Location; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Denmark

Citation

Register to Read

28 May 2008
First Look

First Look: May 28, 2008

goals? Purchase the case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=308030 Can PACIV (Puerto Rico) Serve European Customers? Harvard Business School Case 808-099 Jorge Rodriguez-Gonzalez, PACIV's (Puerto Rico) founding CEO, is considering expanding... View Details

Keywords: Martha Lagace

07 Apr 2003
Research & Ideas

XTV: Xerox’s Attempted Recovery From “Fumbling the Future”

with researchers at PARC. Much of that time was occupied with interviewing prospective customers who had significant problems with document management. For example, a pharmaceutical company that was applying for FDA approval had to manage... View Details

Keywords: by Henry Chesbrough

26 Jul 2010
Research & Ideas

Yes, You Can Raise Prices in a Downturn

have told the Wright brothers, "Don't do it: it's a bad use of capital!" Yet over the past two decades, Ryanair's ROE was often comparable to the best returns in the pharmaceutical business—a traditional example of a... View Details

Keywords: by Sean Silverthorne; Retail; Consumer Products

January 2017 (Revised March 2017)
Case

Royal DSM: From Continuous Transformation to Organic Growth

By: William W. George, Carin-Isabel Knoop and Amram Migdal

Royal DSM CEO Feike Sijbesma was pondering the challenges of shifting DSM’s global organization from the constant transformations of the past 100 years to creating organic growth. When Sijbesma took the helm as CEO in 2007, he further pushed and completed the company’s... View Details

Keywords: Organic Growth; Organizational Change; M＆A; Mergers And Acquisitions; Divestment; Business Ventures; Business Divisions; Business Growth and Maturation; Restructuring; Change; Change Management; Transformation; Transition; Engineering; Chemicals; Mining; Ethics; Values and Beliefs; Finance; Capital Markets; Financial Markets; Food; Globalization; Global Strategy; Globalized Firms and Management; Globalized Markets and Industries; Health; Nutrition; History; Leadership; Leadership Development; Leadership Style; Leading Change; Management; Business or Company Management; Growth and Development Strategy; Growth Management; Management Practices and Processes; Management Style; Organizations; Corporate Social Responsibility and Impact; Mission and Purpose; Organizational Change and Adaptation; Organizational Culture; Organizational Design; Ownership; Public Ownership; Performance; Strategy; Adaptation; Consolidation; Corporate Strategy; Value; Value Creation; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Europe; Netherlands

Citation

Educators

Purchase

Publications

Publications

Show Results For

Show Results For

Are you looking for?

First Look: January 9, 2007

First Look: March 3

How Consumers and Businesses are Reshaping Public Health

First Look: October 7

First Look: August 5

Overview

Note on the U.S. Food and Drug Administration

First Look: February 25

Legacy Partners (A)

First Look at New Ideas and Research: May 23, 2017

Strategic Change and the Jazz Mindset: Exploring Practices That Enhance Dynamic Capabilities for Organizational Improvisation

First Look: January 20

First Look: September 3

First Look: July 1, 2008

CVS Health: Promoting Drug Adherence

What to Know About Locating in a Cluster

First Look: May 28, 2008

XTV: Xerox’s Attempted Recovery From “Fumbling the Future”

Yes, You Can Raise Prices in a Downturn

Royal DSM: From Continuous Transformation to Organic Growth

Are you looking for?